TFM
ITCI

TFC Financial Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

TFC Financial Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$132 – 1106
2025
Q1 		$132 Buy
+1
New +$125 ﹤0.01% 783

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TFC Financial Management's ITCI Position: Q2 2025 in Review

TFC Financial Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 1 share — an estimated $132 sold.

TFC Financial Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $132 in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • TFC Financial Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • TFC Financial Management sold 1 Intra-Cellular Therapies Inc. share in Q2 2025, an estimated $132.
  • TFC Financial Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • TFC Financial Management's Intra-Cellular Therapies Inc. position peaked at $132 in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on TFC Financial Management's 13F filing for Q2 2025, filed 29 Jul 2025.